GLOBAL PHARMA GROUP AS

6230 SYKKYLVEN

Finances

Return on Equity

19,55 %

Current Ratio

0,16

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	530 000	50 000	0	0
Net Income	782 000	−1 791 000	−581 000	−11 000
Total Assets	8 169 000	5 535 000	30 000	599 000
Total Equity	3 999 000	3 217 000	8 000	589 000

Income (NOK)	2022	2021	2020	2019
Revenue	530 000	50 000	0	0
Expenditure	663 000	1 781 000	21 000	12 000
Operating Profit	−134 000	−1 731 000	−21 000	−12 000
Financial Income	937 000	0	0	0
Financial Costs	22 000	60 000	560 000	0
Financial Balance	915 000	−60 000	−560 000	0
Earnings Before Tax	782 000	−1 791 000	−581 000	−11 000
Tax	0	0	0	0
Net Income	782 000	−1 791 000	−581 000	−11 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	7 522 000	50 000	30 000	590 000
Total Current Assets	647 000	5 485 000	0	9 000
Total Assets	8 169 000	5 535 000	30 000	599 000
Total Retained Equity	−1 601 000	−2 383 000	−592 000	−11 000
Total Equity	3 999 000	3 217 000	8 000	589 000
Total Long-Term Debt	0	119 000	0	0
Total Current Debt	4 171 000	2 200 000	22 000	10 000
Total Equity and Debt	8 169 000	5 535 000	30 000	599 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	530 000	50 000	0	0
Other Income	0	0	0	0
Revenue	530 000	50 000	0	0
Cost of Goods Sold	0	7 000	0	0
Salary Costs	492 000	1 550 000	0	0
Depreciation	0	10 000	0	0
Impairment	0	0	0	0
Expenditure	663 000	1 781 000	21 000	12 000
Operating Profit	−134 000	−1 731 000	−21 000	−12 000
Financial Income	937 000	0	0	0
Financial Costs	22 000	60 000	560 000	0
Financial Balance	915 000	−60 000	−560 000	0
Dividends	0	0	0	0
Net Income	782 000	−1 791 000	−581 000	−11 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	20 000	0	0
Total Tangible Assets	0	20 000	0	0
Total Fiancial Fixed Assets	7 522 000	30 000	30 000	590 000
Total Fixed Assets	7 522 000	50 000	30 000	590 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	17 000	104 000	0	9 000
Total Current Assets	647 000	5 485 000	0	9 000
Total Assets	8 169 000	5 535 000	30 000	599 000
Total Equity	3 999 000	3 217 000	8 000	589 000
Short-Term Group Debt	4 008 000	0	22 000	10 000
Total Long-Term Debt	0	119 000	0	0
Creditors	2 000	9 000	0	0
Unpaid Taxes	145 000	57 000	0	0
Dividends	0	0	0	0
Other Current Debt	16 000	2 133 000	0	0
Total Current Debt	4 171 000	2 200 000	22 000	10 000
Total Equity and Debt	8 169 000	5 535 000	30 000	599 000

Financial indicators	2022	2021	2020	2019
Return on Equity	19,55 %	−55,67 %	−7 262,5 %	−1,87 %
Debt-to-Equity Ratio	0	0,04	0	0
Operating Profit Margin	−25,28 %	−3 462 %	-	-
Current Ratio	0,16	2,49	0	0,9
Quick Ratio	0,16	2,49	0	0,9
Equity Ratio	0,49	0,58	0,27	0,98
Gross Profit Margin	100 %	86 %	-	-